FairValueLabs Valuation System Value-Speculation
CCJ

Cameco Corporation (CCJ) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Energy · Uranium

$97.74 Overvalued -0.01 (-0.0%) As of Aug 13, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
8.81
Altman Z-ScoreSafe Zone
$38.40
Fair ValueOvervalued (-154.5%)
2.9
Moat RatingNarrow moat · eroding
TL;DR · Audit Summary

Is Cameco Corporation a safe investment right now?

As of Aug 13, 2026, our estimated fair value (intrinsic value) for Cameco Corporation (CCJ) stock is $38.40, versus a market price of $97.74 — Overvalued. Predicted EPS $0.96 x 40.0 Fair PE.

Cameco Corporation's Altman Z-Score of 8.81 places it in the safe zone. Our fair value estimate is $38.40 (Overvalued). Moat rating: 2.9/5 stars.

Cameco Corporation is part of the Powering AI — Nuclear, Utilities, Cooling & Electrical group in our AI coverage — compare its fair value against every other AI, cloud, and quantum stock through a value investing lens.

Price Chart · CCJ
Section 01 · Financial Health

Could Cameco Corporation go bankrupt? Altman Z-Score analysis

8.81

Z-Score of 8.81 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives CCJ's Z-Score?

Altman Z-Score components for CCJ
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA0.15231.20.18
B · Retained Earnings / Total AssetsRE / TA0.35031.40.49
C · EBIT / Total AssetsEBIT / TA0.08473.30.28
D · Market Cap / Total LiabilitiesMCap / TL12.5280.67.52
E · Revenue / Total AssetsRev / TA0.3381.00.34

How has CCJ's financial health changed over time?

3.0 Safe1.8 Distress0.02.95.98.811.82022202320242025
CCJ Z-Score history
YearZ-ScoreZone
202210.23Safe
20237.6Safe
20248.18Safe
20258.81Safe

Source: Calculated from CCJ's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

Cameco Corporation Fair Value & Intrinsic Value — What Is It Actually Worth?

FVL Fair Value$38.40
vs
Market Price$97.74
Overvalued -154.5% Stock trades 154.5% above our estimated fair value of $38.40.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$0.96Proprietary blend of reported actuals + analyst consensus, weighted by α
Last Year EPS$0.59Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$1.5111 analysts consensus
Trailing P/E165.7xCurrent market pricing
Fair P/E (β discount)40.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)AcceleratingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $130.20 (11 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Cameco Corporation have a durable competitive advantage?

★★½☆☆
Narrow moat · eroding

Moat rating: 2.9/5.

What makes up CCJ's moat score?

ROIC Stability

★★☆☆☆

ROIC variability over the past decade. Score: 2/5.

Gross Margin Trend

★★★★☆

Gross margin trajectory over the past decade. Score: 4/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is CCJ's return on invested capital?

0%-5%0%6%11%16%2022202320242025
CCJ ROIC history
YearROICTrend
20222.2%
20237.3%Rising
20245.2%Declining
202511.1%Rising

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Cameco Corporation's dividend safe?

A Dividend Safety Grade
Yield0.3%
Payout Ratio29.6%
Consecutive Years30
5Y Growth Rate23.0%

Can Cameco Corporation afford its dividend?

Payout ratio is 29.6%. FCF covers the dividend 3.1x. 30 consecutive years of payments.

🌐 Tax-Adjusted Yield (Non-US Investors)
~0.18% after 30% withholding

US dividend withholding tax of 30% applies to non-US tax residents. This rate may be reduced under a tax treaty between the US and your country of residence. The adjusted yield shown assumes the default 30% rate. For informational purposes only — consult a qualified tax advisor.

Section 05 · Financial Summary

Cameco Corporation's key financial metrics

CCJ financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $3.5B $3.1B $1.9B Rising
Net Income $0.6B $0.2B $0.1B Rising
Free Cash Flow $1.1B $0.7B $0.2B Rising
Gross Margin 27.9% 25.0% 12.5% Rising
Section 06 · Lab Signals

Recent events that affect our CCJ analysis

EARNINGS

CCJ earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $0.34. Revenue estimate: $735.7M. Our current Fair Value: $38.40 — a significant beat or miss could shift this estimate.

ANALYST

CCJ analyst consensus: 88% bullish (21 of 24 analysts)

Lab Impact

9 Strong Buy, 12 Buy, 3 Hold, 0 Sell, 0 Strong Sell. Consensus target: $130.20 (33.2% upside). Compare with our independent Fair Value: $38.40.

EARNINGS

CCJ missed EPS estimates by 52.1%

Lab Impact

Reported EPS: $0.18 vs estimate $0.38. Our Fair Value of $38.40 may face downward pressure if the trend continues.

EARNINGS

CCJ beat EPS estimates by 38.1%

Lab Impact

Reported EPS: $0.47 vs estimate $0.34. Earnings strength supports our Fair Value of $38.40 (60.7% below current price).

EARNINGS

CCJ beat EPS estimates by 12.9%

Lab Impact

Reported EPS: $0.50 vs estimate $0.44. Earnings strength supports our Fair Value of $38.40 (60.7% below current price).

DIVIDEND

CCJ paid $0.1720/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 29.6%.

EARNINGS

CCJ missed EPS estimates by 74.5%

Lab Impact

Reported EPS: $0.07 vs estimate $0.27. Our Fair Value of $38.40 may face downward pressure if the trend continues.

EARNINGS

CCJ beat EPS estimates by 37.6%

Lab Impact

Reported EPS: $0.71 vs estimate $0.52. Earnings strength supports our Fair Value of $38.40 (60.7% below current price).

EARNINGS

CCJ missed EPS estimates by 17.5%

Lab Impact

Reported EPS: $0.16 vs estimate $0.19. Our Fair Value of $38.40 may face downward pressure if the trend continues.

EARNINGS

CCJ beat EPS estimates by 12.9%

Lab Impact

Reported EPS: $0.36 vs estimate $0.32. Earnings strength supports our Fair Value of $38.40 (60.7% below current price).

Section 07 · FAQ

Common questions about Cameco Corporation

What is Cameco Corporation stock price today?

Cameco Corporation (CCJ) stock price is $97.74 as of the latest market close, traded on the NYSE exchange.

What does Cameco Corporation do?

Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia. It operates in three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate.

What is Cameco Corporation market cap?

Cameco Corporation has a market capitalization of $42.57B, classifying it as a large-cap stock in the Energy sector.

What sector and industry is CCJ in?

Cameco Corporation operates in the Energy sector, specifically within the Uranium industry. It trades on the NYSE under the ticker symbol CCJ.

Is CCJ stock overvalued or undervalued?

Based on our valuation model, Cameco Corporation trades 154.5% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $38.40
  • Current Price: $97.74
  • Valuation Zone: Overvalued
What is CCJ stock forecast and analyst target price?

Based on 11 Wall Street analysts, the consensus price target for Cameco Corporation is $130.20, implying upside of 33.2% from the current price.

  • Analyst High Target: $177.00
  • Analyst Low Target: $85.40

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Cameco Corporation revenue and earnings growing?

Here are the analyst consensus growth estimates for Cameco Corporation:

  • Revenue growth (current year est.): 0.5%
  • EPS growth (current year est.): 4.7%
  • Revenue growth (next year est.): 13.4%
  • EPS growth (next year est.): 74.7%
What are Cameco Corporation's key financial metrics?
MetricLatestTrend
Revenue$3.5BRising
Net Income$0.6BRising
Free Cash Flow$1.1BRising
Gross Margin27.9%Rising
What is CCJ's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 165.7x
  • Forward P/E (next 12 months est.): 52.2x
  • FairValueLabs Fair P/E: 40.0x
How volatile is CCJ stock?

Cameco Corporation has a beta of 0.99, meaning it is roughly in line with overall market volatility. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Cameco Corporation have?

Cameco Corporation's balance sheet shows:

  • Total Cash: $1.11B
  • Total Debt: $1.22B
  • Net Cash Position: $-109.4M

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Cameco Corporation's free cash flow?

Cameco Corporation generated $50.0M in trailing twelve-month free cash flow (from $941.8M in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Cameco Corporation pay a dividend, and is it safe?

Yes, Cameco Corporation pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 0.2%
  • Payout Ratio: 29.6%
  • Consecutive Years Paid: 30
  • 5-Year Dividend Growth: 23.0%
  • FairValueLabs Safety Grade: A
Is Cameco Corporation at risk of going bankrupt?

Cameco Corporation's Altman Z-Score is 8.81, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Cameco Corporation have a durable competitive advantage?

Cameco Corporation scores 2.9/5 stars (Narrow moat · eroding) in our moat analysis:

  • ROIC Stability: 2/5
  • Gross Margin Trend: 4/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is CCJ's return on equity (ROE)?

Cameco Corporation's return on equity is 5.1%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy CCJ stock?

CCJ shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol CCJ
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is CCJ a value stock or speculative?

FairValueLabs classifies Cameco Corporation as Value-Speculation. It has some value characteristics but carries elevated risk factors that make it speculative. Extra due diligence is recommended.

Who is the CEO of Cameco Corporation?

The current CEO of Cameco Corporation is Mr. Timothy S. Gitzel.

What is CCJ's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $0.59
  • Forward EPS (next 12 months est.): $1.87
  • Analyst consensus EPS (this year): $1.51
  • Analyst consensus EPS (next year): $2.63

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Aug 13, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

CCJ analysis methodology: How we calculate fair value, Z-Scores, and moat ratings